415 related articles for article (PubMed ID: 9443414)
1. Frequent nitric oxide synthase-2 expression in human colon adenomas: implication for tumor angiogenesis and colon cancer progression.
Ambs S; Merriam WG; Bennett WP; Felley-Bosco E; Ogunfusika MO; Oser SM; Klein S; Shields PG; Billiar TR; Harris CC
Cancer Res; 1998 Jan; 58(2):334-41. PubMed ID: 9443414
[TBL] [Abstract][Full Text] [Related]
2. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
[TBL] [Abstract][Full Text] [Related]
3. Expression of nitric oxide synthase isozymes (NOS I-III) by immunohistochemistry and DNA in situ hybridization. Correlation with macrophage presence, vascular endothelial growth factor (VEGF) and oedema volumetric data in 220 glioblastomas.
Ludwig HC; Feiz-Erfan I; Bockermann V; Behnke-Mursch J; Schallock K; Markakis E
Anticancer Res; 2000; 20(1A):299-304. PubMed ID: 10769671
[TBL] [Abstract][Full Text] [Related]
4. Nitric oxide synthase, cyclooxygenase 2, and vascular endothelial growth factor in the angiogenesis of non-small cell lung carcinoma.
Marrogi AJ; Travis WD; Welsh JA; Khan MA; Rahim H; Tazelaar H; Pairolero P; Trastek V; Jett J; Caporaso NE; Liotta LA; Harris CC
Clin Cancer Res; 2000 Dec; 6(12):4739-44. PubMed ID: 11156228
[TBL] [Abstract][Full Text] [Related]
5. The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis.
Welsh SJ; Bellamy WT; Briehl MM; Powis G
Cancer Res; 2002 Sep; 62(17):5089-95. PubMed ID: 12208766
[TBL] [Abstract][Full Text] [Related]
6. p53 and vascular endothelial growth factor regulate tumor growth of NOS2-expressing human carcinoma cells.
Ambs S; Merriam WG; Ogunfusika MO; Bennett WP; Ishibe N; Hussain SP; Tzeng EE; Geller DA; Billiar TR; Harris CC
Nat Med; 1998 Dec; 4(12):1371-6. PubMed ID: 9846573
[TBL] [Abstract][Full Text] [Related]
7. Expression of type 2 nitric oxide synthase and vascular endothelial growth factor in oral dysplasia.
Brennan PA; Umar T; Wilson AW; Mellor TK
J Oral Maxillofac Surg; 2002 Dec; 60(12):1455-60. PubMed ID: 12465010
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide synthase II gene disruption: implications for tumor growth and vascular endothelial growth factor production.
Konopka TE; Barker JE; Bamford TL; Guida E; Anderson RL; Stewart AG
Cancer Res; 2001 Apr; 61(7):3182-7. PubMed ID: 11306506
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor is an in vivo survival factor for tumor endothelium in a murine model of colorectal carcinoma liver metastases.
Bruns CJ; Liu W; Davis DW; Shaheen RM; McConkey DJ; Wilson MR; Bucana CD; Hicklin DJ; Ellis LM
Cancer; 2000 Aug; 89(3):488-99. PubMed ID: 10931447
[TBL] [Abstract][Full Text] [Related]
10. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract.
Brown LF; Berse B; Jackman RW; Tognazzi K; Manseau EJ; Senger DR; Dvorak HF
Cancer Res; 1993 Oct; 53(19):4727-35. PubMed ID: 8402650
[TBL] [Abstract][Full Text] [Related]
11. Implication of vascular endothelial growth factor and p53 status for angiogenesis in noninvasive colorectal carcinoma.
Kondo Y; Arii S; Furutani M; Isigami S; Mori A; Onodera H; Chiba T; Imamura M
Cancer; 2000 Apr; 88(8):1820-7. PubMed ID: 10760758
[TBL] [Abstract][Full Text] [Related]
12. Role of VEGF receptor-1 (Flt-1) in mediating calcium-dependent nitric oxide release and limiting DNA synthesis in human trophoblast cells.
Ahmed A; Dunk C; Kniss D; Wilkes M
Lab Invest; 1997 Jun; 76(6):779-91. PubMed ID: 9194854
[TBL] [Abstract][Full Text] [Related]
13. Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer.
Zhang L; Yang N; Park JW; Katsaros D; Fracchioli S; Cao G; O'Brien-Jenkins A; Randall TC; Rubin SC; Coukos G
Cancer Res; 2003 Jun; 63(12):3403-12. PubMed ID: 12810677
[TBL] [Abstract][Full Text] [Related]
14. Colon epithelial cell death in 2,4,6-trinitrobenzenesulfonic acid-induced colitis is associated with increased inducible nitric-oxide synthase expression and peroxynitrite production.
Yue G; Lai PS; Yin K; Sun FF; Nagele RG; Liu X; Linask KK; Wang C; Lin KT; Wong PY
J Pharmacol Exp Ther; 2001 Jun; 297(3):915-25. PubMed ID: 11356911
[TBL] [Abstract][Full Text] [Related]
15. Nitric oxide synthase expression and enzymatic activity in human brain tumors.
Broholm H; Rubin I; Kruse A; Braendstrup O; Schmidt K; Skriver EB; Lauritzen M
Clin Neuropathol; 2003; 22(6):273-81. PubMed ID: 14672505
[TBL] [Abstract][Full Text] [Related]
16. Carboxyamido-triazole inhibits angiogenesis by blocking the calcium-mediated nitric-oxide synthase-vascular endothelial growth factor pathway.
Bauer KS; Cude KJ; Dixon SC; Kruger EA; Figg WD
J Pharmacol Exp Ther; 2000 Jan; 292(1):31-7. PubMed ID: 10604929
[TBL] [Abstract][Full Text] [Related]
17. Angiopoietin-2 is related to tumor angiogenesis in gastric carcinoma: possible in vivo regulation via induction of proteases.
Etoh T; Inoue H; Tanaka S; Barnard GF; Kitano S; Mori M
Cancer Res; 2001 Mar; 61(5):2145-53. PubMed ID: 11280779
[TBL] [Abstract][Full Text] [Related]
18. Expression of endothelial nitric oxide synthase and vascular endothelial growth factor in oral squamous cell carcinoma: its correlation with angiogenesis and disease progression.
Shang ZJ; Li JR
J Oral Pathol Med; 2005 Mar; 34(3):134-9. PubMed ID: 15689226
[TBL] [Abstract][Full Text] [Related]
19. Regulation of nitric oxide synthase 2 in rabbit corneal cells.
O'Brien WJ; Heimann T; Tsao LS; Seet BT; McFadden G; Taylor JL
Invest Ophthalmol Vis Sci; 2001 Mar; 42(3):713-9. PubMed ID: 11222532
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M
Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
